Edgewise Therapeutics Inc (EWTX) — Financial Flexibility Index
Edgewise Therapeutics Inc (EWTX) has a Financial Flexibility Index of -1.67x as of March 2026. Free cash flow of $-42.28 Million (operating CF $-42.54 Million minus capex $260.00K) represents -2% of total liabilities ($25.32 Million). Also explore Edgewise Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Edgewise Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Edgewise Therapeutics Inc across 7 annual periods. Check asset allocation strategy of Edgewise Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Edgewise Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Edgewise Therapeutics Inc. For the full company profile including market capitalisation, see EWTX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.73x | $-143.56 Million | $-143.82 Million | $30.35 Million | ▼ -21.2% |
| 2024 | -3.90x | $-107.72 Million | $-109.03 Million | $27.60 Million | ▲ +4.0% |
| 2023 | -4.07x | $-86.20 Million | $-91.95 Million | $21.20 Million | ▼ -76.0% |
| 2022 | -2.31x | $-47.09 Million | $-52.63 Million | $20.39 Million | ▲ +23.7% |
| 2021 | -3.03x | $-32.84 Million | $-33.51 Million | $10.85 Million | ▼ -3351.3% |
| 2020 | -0.09x | $-14.43 Million | $-14.63 Million | $164.56 Million | ▲ +59.6% |
| 2019 | -0.22x | $-8.99 Million | $-9.17 Million | $41.39 Million | — |